Artivion, Inc. announced its fourth quarter and full year 2025 financial results, reporting GAAP revenue of $116.0 million for Q4 and $441.3 million for the full year. The company provided 2026 financial outlook, expecting revenue between $486 and $504 million and adjusted EBITDA between $105 and $110 million.
Key takeaways
Q4 2025 GAAP revenue was $116.0 million, compared to $97.3 million in Q4 2024.
Full year 2025 GAAP net income was $9.8 million, versus a net loss of $(13.4) million in 2024.
Q4 2025 Non-GAAP net income was $8.6 million, or $0.17 per fully diluted share.
Full year 2025 Adjusted EBITDA increased 26% to $89.6 million.
The company filed the fourth and final module of the pre-market approval application (PMA) to the FDA for the AMDS Hybrid Prothesis.
2026 guidance projects revenue of $486 to $504 million and adjusted EBITDA of $105 to $110 million.